China Biosimilar Drug Industry Market Analysis & Forecast 2018-2023
In the China Biosimilar Drug Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.
It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.
The Major players reported in the market include:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
company 5
company 6
company 7
company 8
company 9
China Biosimilar Drug Market: Product Segment Analysis
Injection
Tablets
Others
China Biosimilar Drug Market: Application Segment Analysis
Trastuzumab
Ankylosing Spondylitis
Others
Reasons for Buying this Report
It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.
The Major players reported in the market include:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
company 5
company 6
company 7
company 8
company 9
China Biosimilar Drug Market: Product Segment Analysis
Injection
Tablets
Others
China Biosimilar Drug Market: Application Segment Analysis
Trastuzumab
Ankylosing Spondylitis
Others
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
China Biosimilar Drug Industry Market Analysis & Forecast 2018-2023
CHAPTER 1 BIOSIMILAR DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Market Segmentation by Type
1.2.1 China Production Market Share of Biosimilar Drug by Injectionn 2017
1.2.1 Injection
1.2.2 Tablets
1.2.3 Others
1.3 Biosimilar Drug Market Segmentation by Application
1.3.1 Biosimilar Drug Consumption Market Share by Application in 2017
1.3.2 Trastuzumab
1.3.3 Ankylosing Spondylitis
1.3.4 Others
1.4 China Market Size Sales (Value) and Revenue (Volume) of Biosimilar Drug (2013-2023)
CHAPTER 2 CHINA ECONOMIC IMPACT ON BIOSIMILAR DRUG INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Biosimilar Drug Industry
CHAPTER 3 CHINA BIOSIMILAR DRUG MARKET COMPETITION BY MANUFACTURERS
3.1 China Biosimilar Drug Production and Share by Manufacturers (2016 and 2017)
3.2 China Biosimilar Drug Revenue and Share by Manufacturers (2016 and 2017)
3.3 China Biosimilar Drug Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Biosimilar Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Biosimilar Drug Market Competitive Situation and Trends
3.5.1 Biosimilar Drug Market Concentration Rate
3.5.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA BIOSIMILAR DRUG CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2013-2018)
4.1 China Biosimilar Drug Capacity, Production and Growth (2013-2018)
4.2 China Biosimilar Drug Revenue and Growth (2013-2018)
4.3 China Biosimilar Drug Production, Consumption, Export and Import (2013-2018)
CHAPTER 5 CHINA BIOSIMILAR DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Biosimilar Drug Production and Market Share by Type (2013-2018)
5.2 China Biosimilar Drug Revenue and Market Share by Type (2013-2018)
5.3 China Biosimilar Drug Price by Type (2013-2018)
5.4 China Biosimilar Drug Production Growth by Type (2013-2018)
CHAPTER 6 CHINA BIOSIMILAR DRUG MARKET ANALYSIS BY APPLICATION
6.1 China Biosimilar Drug Consumption and Market Share by Application (2013-2018)
6.2 China Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA BIOSIMILAR DRUG MANUFACTURERS ANALYSIS
7.1 CP Guojian Pharma
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Business Overview
7.2 Biotech Pharma
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Business Overview
7.3 Celgen Pharma
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Business Overview
7.4 Henlius
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Business Overview
7.5 company
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Business Overview
7.6 company
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Business Overview
7.7 company
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Business Overview
7.8 company
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Business Overview
7.9 company
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Business Overview
…
CHAPTER 8 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS
8.1 Biosimilar Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biosimilar Drug
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Biosimilar Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA BIOSIMILAR DRUG MARKET FORECAST (2018-2023)
12.1 China Biosimilar Drug Production, Revenue Forecast (2018-2023)
12.2 China Biosimilar Drug Production, Consumption Forecast by Regions (2018-2023)
12.3 China Biosimilar Drug Production Forecast by Type (2018-2023)
12.4 China Biosimilar Drug Consumption Forecast by Application (2018-2023)
12.5 Biosimilar Drug Price Forecast (2018-2023)
CHAPTER 13 APPENDIX
CHAPTER 1 BIOSIMILAR DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Market Segmentation by Type
1.2.1 China Production Market Share of Biosimilar Drug by Injectionn 2017
1.2.1 Injection
1.2.2 Tablets
1.2.3 Others
1.3 Biosimilar Drug Market Segmentation by Application
1.3.1 Biosimilar Drug Consumption Market Share by Application in 2017
1.3.2 Trastuzumab
1.3.3 Ankylosing Spondylitis
1.3.4 Others
1.4 China Market Size Sales (Value) and Revenue (Volume) of Biosimilar Drug (2013-2023)
CHAPTER 2 CHINA ECONOMIC IMPACT ON BIOSIMILAR DRUG INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Biosimilar Drug Industry
CHAPTER 3 CHINA BIOSIMILAR DRUG MARKET COMPETITION BY MANUFACTURERS
3.1 China Biosimilar Drug Production and Share by Manufacturers (2016 and 2017)
3.2 China Biosimilar Drug Revenue and Share by Manufacturers (2016 and 2017)
3.3 China Biosimilar Drug Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Biosimilar Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Biosimilar Drug Market Competitive Situation and Trends
3.5.1 Biosimilar Drug Market Concentration Rate
3.5.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA BIOSIMILAR DRUG CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2013-2018)
4.1 China Biosimilar Drug Capacity, Production and Growth (2013-2018)
4.2 China Biosimilar Drug Revenue and Growth (2013-2018)
4.3 China Biosimilar Drug Production, Consumption, Export and Import (2013-2018)
CHAPTER 5 CHINA BIOSIMILAR DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Biosimilar Drug Production and Market Share by Type (2013-2018)
5.2 China Biosimilar Drug Revenue and Market Share by Type (2013-2018)
5.3 China Biosimilar Drug Price by Type (2013-2018)
5.4 China Biosimilar Drug Production Growth by Type (2013-2018)
CHAPTER 6 CHINA BIOSIMILAR DRUG MARKET ANALYSIS BY APPLICATION
6.1 China Biosimilar Drug Consumption and Market Share by Application (2013-2018)
6.2 China Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA BIOSIMILAR DRUG MANUFACTURERS ANALYSIS
7.1 CP Guojian Pharma
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Business Overview
7.2 Biotech Pharma
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Business Overview
7.3 Celgen Pharma
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Business Overview
7.4 Henlius
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Business Overview
7.5 company
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Business Overview
7.6 company
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Business Overview
7.7 company
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Business Overview
7.8 company
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Business Overview
7.9 company
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Business Overview
…
CHAPTER 8 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS
8.1 Biosimilar Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biosimilar Drug
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Biosimilar Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA BIOSIMILAR DRUG MARKET FORECAST (2018-2023)
12.1 China Biosimilar Drug Production, Revenue Forecast (2018-2023)
12.2 China Biosimilar Drug Production, Consumption Forecast by Regions (2018-2023)
12.3 China Biosimilar Drug Production Forecast by Type (2018-2023)
12.4 China Biosimilar Drug Consumption Forecast by Application (2018-2023)
12.5 Biosimilar Drug Price Forecast (2018-2023)
CHAPTER 13 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Biosimilar Drug
Figure China Production Market Share of Biosimilar Drug by Injectionn 2017
Table Biosimilar Drug Consumption Market Share by Application in 2017
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2023)
Table China Biosimilar Drug Capacity of Key Manufacturers (2016 and 2017)
Table China Biosimilar Drug Capacity Market Share of Key Manufacturers (2016 and 2017)
Figure China Biosimilar Drug Capacity of Key Manufacturers in 2016
Figure China Biosimilar Drug Capacity of Key Manufacturers in 2017
Table China Biosimilar Drug Production of Key Manufacturers (2016 and 2017)
Table China Biosimilar Drug Production Share by Manufacturers (2016 and 2017)
Figure 2015 Biosimilar Drug Production Share by Manufacturers
Figure 2016 Biosimilar Drug Production Share by Manufacturers
Table China Biosimilar Drug Revenue (Million USD) by Manufacturers (2016 and 2017)
Table China Biosimilar Drug Revenue Share by Manufacturers (2016 and 2017)
Table 2015 China Biosimilar Drug Revenue Share by Manufacturers
Table 2016 China Biosimilar Drug Revenue Share by Manufacturers
Table China Market Biosimilar Drug Average Price of Key Manufacturers (2016 and 2017)
Figure China Market Biosimilar Drug Average Price of Key Manufacturers in 2016
Table Manufacturers Biosimilar Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Biosimilar Drug Product Type
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
Figure Church & Dwight Biosimilar Drug Market Share (2013-2018)
Table CP Guojian Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CP Guojian Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table CP Guojian Pharma Biosimilar Drug Market Share (2013-2018)
Table Biotech Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biotech Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Biotech Pharma Biosimilar Drug Market Share (2013-2018)
Table Celgen Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgen Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Celgen Pharma Biosimilar Drug Market Share (2013-2018)
Table Henlius Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Henlius Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Henlius Biosimilar Drug Market Share (2013-2018)
Table company 5 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 5 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 5 Biosimilar Drug Market Share (2013-2018)
Table company 6 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 6 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 6 Biosimilar Drug Market Share (2013-2018)
Table company 7 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 7 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 7 Biosimilar Drug Market Share (2013-2018)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 8 Biosimilar Drug Market Share (2013-2018)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 9 Biosimilar Drug Market Share (2013-2018)
Figure Production Revenue Share of Biosimilar Drug by Type (2013-2018)
Figure 2015 Revenue Market Share of Biosimilar Drug by Type
Table China Biosimilar Drug Price by Type (2013-2018)
Figure China Biosimilar Drug Production Growth by Type (2013-2018)
Table China Biosimilar Drug Consumption by Application (2013-2018)
Table China Biosimilar Drug Consumption Market Share by Application (2013-2018)
Figure China Biosimilar Drug Consumption Market Share by Application in 2016
Table China Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
Figure China Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure China Biosimilar Drug Capacity, Production and Growth Rate Forecast (2018-2023)
Figure China Biosimilar Drug Revenue and Growth Rate Forecast (2018-2023)
Table China Biosimilar Drug Production, Import, Export and Consumption Forecast (2018-2023)
Table China Biosimilar Drug Production Forecast by Type (2018-2023)
Table China Biosimilar Drug Consumption Forecast by Application (2018-2023)
COMPANIES MENTIONED
CP Guojian Pharma Biotech Pharma Celgen Pharma Henlius
Figure Picture of Biosimilar Drug
Figure China Production Market Share of Biosimilar Drug by Injectionn 2017
Table Biosimilar Drug Consumption Market Share by Application in 2017
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2023)
Table China Biosimilar Drug Capacity of Key Manufacturers (2016 and 2017)
Table China Biosimilar Drug Capacity Market Share of Key Manufacturers (2016 and 2017)
Figure China Biosimilar Drug Capacity of Key Manufacturers in 2016
Figure China Biosimilar Drug Capacity of Key Manufacturers in 2017
Table China Biosimilar Drug Production of Key Manufacturers (2016 and 2017)
Table China Biosimilar Drug Production Share by Manufacturers (2016 and 2017)
Figure 2015 Biosimilar Drug Production Share by Manufacturers
Figure 2016 Biosimilar Drug Production Share by Manufacturers
Table China Biosimilar Drug Revenue (Million USD) by Manufacturers (2016 and 2017)
Table China Biosimilar Drug Revenue Share by Manufacturers (2016 and 2017)
Table 2015 China Biosimilar Drug Revenue Share by Manufacturers
Table 2016 China Biosimilar Drug Revenue Share by Manufacturers
Table China Market Biosimilar Drug Average Price of Key Manufacturers (2016 and 2017)
Figure China Market Biosimilar Drug Average Price of Key Manufacturers in 2016
Table Manufacturers Biosimilar Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Biosimilar Drug Product Type
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Biosimilar Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
Figure Church & Dwight Biosimilar Drug Market Share (2013-2018)
Table CP Guojian Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CP Guojian Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table CP Guojian Pharma Biosimilar Drug Market Share (2013-2018)
Table Biotech Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biotech Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Biotech Pharma Biosimilar Drug Market Share (2013-2018)
Table Celgen Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgen Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Celgen Pharma Biosimilar Drug Market Share (2013-2018)
Table Henlius Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Henlius Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Henlius Biosimilar Drug Market Share (2013-2018)
Table company 5 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 5 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 5 Biosimilar Drug Market Share (2013-2018)
Table company 6 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 6 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 6 Biosimilar Drug Market Share (2013-2018)
Table company 7 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 7 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 7 Biosimilar Drug Market Share (2013-2018)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 8 Biosimilar Drug Market Share (2013-2018)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biosimilar Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table company 9 Biosimilar Drug Market Share (2013-2018)
Figure Production Revenue Share of Biosimilar Drug by Type (2013-2018)
Figure 2015 Revenue Market Share of Biosimilar Drug by Type
Table China Biosimilar Drug Price by Type (2013-2018)
Figure China Biosimilar Drug Production Growth by Type (2013-2018)
Table China Biosimilar Drug Consumption by Application (2013-2018)
Table China Biosimilar Drug Consumption Market Share by Application (2013-2018)
Figure China Biosimilar Drug Consumption Market Share by Application in 2016
Table China Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
Figure China Biosimilar Drug Consumption Growth Rate by Application (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure China Biosimilar Drug Capacity, Production and Growth Rate Forecast (2018-2023)
Figure China Biosimilar Drug Revenue and Growth Rate Forecast (2018-2023)
Table China Biosimilar Drug Production, Import, Export and Consumption Forecast (2018-2023)
Table China Biosimilar Drug Production Forecast by Type (2018-2023)
Table China Biosimilar Drug Consumption Forecast by Application (2018-2023)
COMPANIES MENTIONED
CP Guojian Pharma Biotech Pharma Celgen Pharma Henlius
